Compare DexCom, Inc. (DXCM) vs Enovix Corporation (ENVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Enovix Corporation — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Enovix Corporation trades at $4.85 (market cap $1.06B). The key difference: DexCom, Inc. is far larger — about 31.9× Enovix Corporation's market cap, and DexCom, Inc. is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals.
| DXCM | ENVX | |
|---|---|---|
Market Cap | $33.79B | $1.06B |
Sector | Health | Technology |
52-Week High | $89.53 | $13.19 |
52-Week Low | $54.84 | $3.68 |
Enterprise Value | $33.24B | $1.07B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Enovix Corporation
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →
